
													
															
															Year
															DEALS // DEV.
															Country
															
															Therapeutic Area
															Study Phase
															Deal Type
															Product Type
															Dosage Form
															Lead Product
															Target

 Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.                    
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Famotidine,Calcium Carbonate,Magnesium Hydroxide
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Akums Launches Dual Action Heartburn Relief Chewable Tablet
Details : Dual action heartburn relief chewable tablet, consisting Famotidine (H2 receptor antagonist), Calcium Carbonate and Magnesium Hydroxide have been approved and launched in indian market.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
October 12, 2024
Lead Product(s) : Famotidine,Calcium Carbonate,Magnesium Hydroxide
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Magnesium Hydroxide
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Sponsor : Gunnar Kjems APS | GCP-unit at Aarhus University Hospital, Aarhus, Denmark | Aarhus University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Bronchial Challenge Test of Magnesium-treated Asthmatics
Details : Magnesium Hydroxide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Asthma.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 07, 2010
Lead Product(s) : Magnesium Hydroxide
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Sponsor : Gunnar Kjems APS | GCP-unit at Aarhus University Hospital, Aarhus, Denmark | Aarhus University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Magnesium Hydroxide
Therapeutic Area : Pulmonary/Respiratory Diseases
Study Phase : Undisclosed
Sponsor : Gunnar Kjems APS | Aarhus University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Daily Magnesium-treatment of Patients With Chronic Obstructive Pulmonary Disease
Details : Magnesium Hydroxide is a Other Small Molecule drug candidate, which is currently being evaluated in clinical studies for the treatment of Pulmonary Disease, Chronic Obstructive.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
May 07, 2010
Lead Product(s) : Magnesium Hydroxide
Therapeutic Area : Pulmonary/Respiratory Diseases
Highest Development Status : Undisclosed
Sponsor : Gunnar Kjems APS | Aarhus University Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
